Embecta share price today

(EMBC)

Embecta share price is $20.65 & ₹1,768.67 as on 1 Jan 2025, 2.30 'hrs' IST

$20.65

▲

0.15

(0.73%)

Market is closed - opens 8 PM, 02 Jan 2025

View live Embecta share price in Dollar and Rupees. Guide to invest in Embecta from India. Also see the sentimental analysis on Indian investors investing in Embecta. Get details on the Indian mutual funds that are investing in Embecta. Get Analyst recommendations and forecasts along with all the Embecta's financials.

Embecta share price movements

Today's Low: $20.51
Today's High: $20.85
$20.65
0.68%
Downside
Day's Volatility :1.63%
Upside
0.96%
52 Weeks Low: $9.93
52 Weeks High: $21.48
$20.65
51.94%
Downside
52 Weeks Volatility :53.79%
Upside
3.86%

Embecta Returns

Period	Embecta Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	55.38%	-10.0%	0.0%
6 Months	80.19%	-4.7%	0.0%
1 Year	12.9%	-0.9%	0.0%
3 Years	-31.12%	-2.4%	-21.2%

Embecta Key Statistics

in dollars & INR

Previous Close	$20.5
Open	$20.58
Today's High	$20.8507
Today's Low	$20.51
Market Capitalization	$1.2B
Today's Volume	$336.9K
52 Week High	$21.48
52 Week Low	$9.925
Revenue TTM	$1.1B
EBITDA	$230.4M
Earnings Per Share (EPS)	$1.34
PE Ratio	15.41
Dividend Yield	4.16%
Profit Margin	6.23%
Quarterly Earnings Growth YOY	-0.04%
Return On Equity TTM	0.0%

How to invest in Embecta from India?

It is very easy for Indian residents to invest directly in Embecta from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Embecta stock in both Indian Rupees (INR) and US Dollars (USD). Search for Embecta or EMBC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Embecta or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Embecta shares which would translate to 0.041 fractional shares of Embecta as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Embecta, in just a few clicks!

Returns in Embecta for Indian investors in Rupees

Investment Value

₹1,00,000

Embecta investment value today

Current value as on today

₹1,15,770

Returns

₹15,770

(+15.77%)

Returns from Embecta Stock

₹12,903 (+12.9%)

Dollar Returns

₹2,867 (+2.87%)

Indian investors sentiment towards Embecta

Period: Oct 3, 2024 to Jan 1, 2025. Change in 30 Days versus previous period

Search volume for Embecta on INDmoney from India has grown in the last 30 days as on Jan 2, 2025. 7% more investors are searching Embecta in the last 30 days versus the previous period.

Global Institutional Holdings in Embecta

BlackRock Inc
15.82%
Vanguard Group Inc
12.04%
River Road Asset Management, LLC
5.98%
American Century Companies Inc
5.19%
Deerfield Management Co
4.70%
Yacktman Asset Management Co
4.35%

Analyst Recommendation on Embecta

Sell

0%Buy

44%Hold

55%Sell

Based on 9 Wall street analysts offering stock ratings for Embecta(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Embecta

What analysts predicted

Upside of 1.94%

Current:

$20.65

Target:

$21.05

Insights on Embecta

Price Movement
In the last 3 months, EMBC stock has moved up by 48.1%
Increasing Revenue
Revenue is up for the last 2 quarters, 272.5M → 286.1M (in $), with an average increase of 4.8% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, 28.9M → 14.6M (in $), with an average decrease of 24.9% per quarter
EMBC vs ISRG (1 yr)
In the last 1 year, Intuitive Surgical, Inc. has given 57.7% return, outperforming this stock by 49.4%
Price to Sales
ForEMBC every $1 of sales, investors are willing to pay $1.1, whereas for Intuitive Surgical, Inc., the investors are paying $23.5 for every $1 of sales.

Embecta Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$1.1B	-
Net Income	$432.0M	-
Net Profit Margin	38.95%	-

	FY20	Y/Y Change
Revenue	$1.1B	↓ 2.12%
Net Income	$427.6M	↓ 1.02%
Net Profit Margin	39.39%	↑ 0.44%

	FY21	Y/Y Change
Revenue	$1.2B	↑ 7.32%
Net Income	$414.8M	↓ 2.99%
Net Profit Margin	35.61%	↓ 3.78%

	FY22	Y/Y Change
Revenue	$1.1B	↓ 3.05%
Net Income	$223.6M	↓ 46.09%
Net Profit Margin	19.8%	↓ 15.81%

	FY23	Y/Y Change
Revenue	$1.1B	↓ 0.77%
Net Income	$70.4M	↓ 68.52%
Net Profit Margin	6.28%	↓ 13.52%

	FY24	Y/Y Change
Revenue	$1.1B	↑ 0.21%
Net Income	$78.3M	↑ 11.22%
Net Profit Margin	6.97%	↑ 0.69%

	Q2 FY23	Q/Q Change
Revenue	$286.1M	↑ 3.25%
Net Income	$15.2M	↑ 8.57%
Net Profit Margin	5.31%	↑ 0.26%

	Q3 FY23	Q/Q Change
Revenue	$281.9M	↓ 1.47%
Net Income	$6.0M	↓ 60.53%
Net Profit Margin	2.13%	↓ 3.18%

	Q4 FY23	Q/Q Change
Revenue	$277.3M	↓ 1.63%
Net Income	$20.1M	↑ 235.0%
Net Profit Margin	7.25%	↑ 5.12%

	Q1 FY24	Q/Q Change
Revenue	$287.2M	↑ 3.57%
Net Income	$28.9M	↑ 43.78%
Net Profit Margin	10.06%	↑ 2.81%

	Q2 FY24	Q/Q Change
Revenue	$272.5M	↓ 5.12%
Net Income	$14.7M	↓ 49.13%
Net Profit Margin	5.39%	↓ 4.67%

	Q3 FY24	Q/Q Change
Revenue	$286.1M	↑ 4.99%
Net Income	$14.6M	↓ 0.68%
Net Profit Margin	5.1%	↓ 0.29%

	FY19	Y/Y Change
Profit	$786.0M	-

	FY20	Y/Y Change
Profit	$762.6M	↓ 2.98%

	FY21	Y/Y Change
Profit	$800.0M	↑ 4.9%

	FY22	Y/Y Change
Profit	$774.9M	↓ 3.14%

	FY23	Y/Y Change
Profit	$749.9M	↓ 3.23%

	FY24	Y/Y Change
Profit	$735.2M	↓ 1.96%

	Q2 FY23	Q/Q Change
Profit	$189.5M	↓ 0.16%

	Q3 FY23	Q/Q Change
Profit	$181.8M	↓ 4.06%

	Q4 FY23	Q/Q Change
Profit	$185.9M	↑ 2.26%

	Q1 FY24	Q/Q Change
Profit	$184.2M	↓ 0.91%

	Q2 FY24	Q/Q Change
Profit	$190.1M	↑ 3.2%

	Q3 FY24	Q/Q Change
Profit	$173.8M	↓ 8.57%

	FY19	Y/Y Change
Operating Cash Flow	$505.0M	-
Investing Cash Flow	$-69.0M	-
Financing Cash Flow	$-436.0M	-

	FY20	Y/Y Change
Operating Cash Flow	$498.5M	↓ 1.29%
Investing Cash Flow	$-42.0M	↓ 39.13%
Financing Cash Flow	$-456.6M	↑ 4.72%

	FY21	Y/Y Change
Operating Cash Flow	$456.0M	↓ 8.53%
Investing Cash Flow	$-39.0M	↓ 7.14%
Financing Cash Flow	$-417.0M	↓ 8.67%

	FY22	Y/Y Change
Operating Cash Flow	$412.2M	↓ 9.61%
Investing Cash Flow	$-24.0M	↓ 38.46%
Financing Cash Flow	$-48.0M	↓ 88.49%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-9.3M	↓ 28.46%
Investing Cash Flow	$-6.8M	↑ 17.24%
Financing Cash Flow	$-12.2M	↓ 41.06%

Embecta Technicals Summary

Sell

Neutral

Buy

Embecta is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Embecta Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Embecta Corp	1.08%	80.19%	12.9%	-31.12%	-31.12%
Intuitive Surgical, Inc.	-3.65%	17.62%	62.03%	44.99%	162.84%
Resmed Inc.	-7.38%	17.43%	37.94%	-11.88%	46.57%
Becton, Dickinson And Company	2.54%	-0.39%	-5.66%	-10.4%	-17.01%
West Pharmaceutical Services Inc	1.76%	1.55%	-3.17%	-26.54%	115.19%
Alcon Ag	-2.81%	-5.1%	13.41%	-2.57%	48.1%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Embecta Corp	15.41	15.41	NA	2.66	0.0	0.1	0.04	-13.24
Intuitive Surgical, Inc.	84.05	84.05	3.91	6.86	0.16	0.08	NA	43.75
Resmed Inc.	30.29	30.29	1.74	9.35	0.24	0.13	0.01	35.39
Becton, Dickinson And Company	38.78	38.78	1.04	14.37	0.06	0.03	0.02	89.47
West Pharmaceutical Services Inc	48.53	48.53	6.12	6.66	0.18	0.1	0.0	37.96
Alcon Ag	36.28	36.28	3.1	3.03	0.06	0.03	0.0	43.25

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Embecta Corp	Sell	$1.2B	-31.12%	15.41	6.23%
Intuitive Surgical, Inc.	Buy	$185.9B	162.84%	84.05	28.51%
Resmed Inc.	Buy	$33.6B	46.57%	30.29	23.15%
Becton, Dickinson And Company	Buy	$65.8B	-17.01%	38.78	7.13%
West Pharmaceutical Services Inc	Buy	$23.7B	115.19%	48.53	17.37%
Alcon Ag	Buy	$42.1B	48.1%	36.28	11.89%

About Embecta

Organization	Embecta
Employees	2200
CEO	Mr. Devdatt Kurdikar
Industry	Healthcare

Management People of Embecta

Name	Title
Mr. Devdatt Kurdikar	President, CEO & Director
Mr. Jacob P. Elguicze	Senior VP & CFO
Mr. Jeffrey Z. Mann	Senior VP, General Counsel, Head of Business Development & Corporate Secretary
Mr. Shaun Curtis	Senior Vice President of Global Manufacturing & Supply Chain
Ms. Colleen Riley	Senior VP & Chief Technology Officer
Mr. Pravesh Khandelwal	VP & Head of Investor Relations
Ms. Ginny Blocki	Senior Vice President of Global Marketing & Product Management
Ms. Jean M. Casner	Senior VP & Chief Human Resources Officer
Mr. Tom Blount	Senior VP & President of North America
Mr. Slobodan Radumilo	Senior VP & President of International

Important FAQs about investing in Embecta from India :

What is Embecta share price today?

Embecta share price today stands at $20.65, Open: $20.58 ; Previous Close: $20.50 ; High: $20.85 ; Low: $20.51 ; 52 Week High: $21.48 ; 52 Week Low: $9.93. The stock opens at $20.58, after a previous close of $20.50. The stock reached a daily high of $20.85 and a low of $20.51, with a 52-week high of $21.48 and a 52-week low of $9.93.

Can Indians buy Embecta shares?

Yes, Indians can invest in the Embecta (EMBC) from India.

With INDmoney, you can buy Embecta at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Embecta at zero transaction cost.

How can I buy Embecta shares from India?

It is very easy to buy Embecta from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Embecta be purchased?

Yes, you can buy fractional shares of Embecta with INDmoney app.

What are the documents required to start investing in Embecta stocks?

To start investing in Embecta, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.